Equillium (EQ) Share-based Compensation (2018 - 2026)

Equillium's (EQ) quarterly Share-based Compensation came in at $930000.0 in Q1 2026, up 49.76% year-on-year from $621000.0 in Q1 2025, and up 189.68% on a QoQ basis from -$1.0 million in Q4 2025.

Equillium (EQ) Share-based Compensation (2018 - 2026) Analysis & Trends

Equillium (EQ) has 9 years of Share-based Compensation data on file, last reported at $930000.0 in Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 49.76% year-over-year to $930000.0 in Q1 2026; TTM through Mar 2026 was $1.3 million, a 60.72% decrease from a year earlier, with the FY2025 full-year figure at $7.7 million, up 105.33% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $930000.0, up from -$1.0 million in the prior quarter.
  • Over the last five years, Share-based Compensation for EQ reached as high as $8.4 million in Q3 2025 and fell as low as -$3.7 million in Q4 2022.
  • Historically, Share-based Compensation has averaged $991176.5 across 5 years, with a median of $952000.0 in 2024.
  • Across the five-year window, Share-based Compensation jumped 6505.56% in 2022 and slumped 226.31% in 2025, its largest moves.
  • Year by year, Share-based Compensation stood at -$3.7 million in 2022, then jumped by 128.0% to $1.0 million in 2023, then slipped by 21.51% to $821000.0 in 2024, then slumped by 226.31% to -$1.0 million in 2025, then soared by 189.68% to $930000.0 in 2026.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $930000.0 in Q1 2026, -$1.0 million in Q4 2025, and $8.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Equillium 258.99 Mn 258.99 Mn - 930,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 930,000.00
Mar 31, 2026 930,000.00
Dec 31, 2025 -1.04 Mn
Dec 31, 2025 -1.04 Mn
Sep 30, 2025 8.40 Mn
Sep 30, 2025 8.40 Mn
Jun 30, 2025 2.70 Mn
Jun 30, 2025 2.70 Mn
Mar 31, 2025 621,000.00
Mar 31, 2025 621,000.00
Dec 31, 2024 821,000.00
Dec 31, 2024 821,000.00
Sep 30, 2024 1.01 Mn
Sep 30, 2024 1.01 Mn
Jun 30, 2024 952,000.00
Jun 30, 2024 952,000.00
Mar 31, 2024 972,000.00
Mar 31, 2024 972,000.00
Dec 31, 2023 1.05 Mn
Dec 31, 2023 1.05 Mn